Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wu Ling Capsule for Type 2 Diabetes With Depression
ChiCTR-IPR-16008486Phase 4Recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Oct 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and major depressive disorder (MDD) comparing Wu Ling Capsule with Placebo (2 arms). Primary endpoint: Depression state. Started Oct 2016; status: recruiting.
02
Drugs
wulingshen
03
Conditions
type 2 diabetes mellitus (T2DM)major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-IPR-16008486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008486.